The human CYP3A subfamily: Practical considerations

被引：183

作者：

Wrighton, SA

Schuetz, EG

Thummel, KE

Shen, DD

Korzekwa, KR

Watkins, PB

机构：

[1] Lilly Corp Ctr, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

[2] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA

[3] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA

[4] Univ Washington, Dept Pharm, Seattle, WA 98195 USA

[5] Camitro Corp, Menlo Pk, CA 94025 USA

[6] Univ N Carolina, Chapel Hill, NC 27599 USA

来源：

DRUG METABOLISM REVIEWS | 2000年 / 32卷 / 3-4期

关键词：

D O I：

10.1081/DMR-100102338

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：339 / 361

页数：23

共 104 条

[1] DOSE OF MIDAZOLAM SHOULD BE REDUCED DURING DILTIAZEM AND VERAPAMIL TREATMENTS [J].

BACKMAN, JT ;

OLKKOLA, KT ;

ARANKO, K ;

HIMBERG, JJ ;

NEUVONEN, PJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (03) :221-225

[2] Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4 [J].

Ball, SE ;

Scatina, JA ;

Kao, J ;

Ferron, GM ;

Fruncillo, R ;

Mayer, P ;

Weinryb, I ;

Guida, M ;

Hopkins, PJ ;

Warner, N ;

Hall, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) :288-294

[3] Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells [J].

Barnes, KM ;

Dickstein, B ;

Cutler, GB ;

Fojo, T ;

Bates, SE .

BIOCHEMISTRY, 1996, 35 (15) :4820-4827

[4] INHIBITION OF ALFENTANIL METABOLISM BY ERYTHROMYCIN [J].

BARTKOWSKI, RR ;

GOLDBERG, ME ;

LARIJANI, GE ;

BOERNER, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) :99-102

[5] ISOLATION AND SEQUENCE DETERMINATION OF A CDNA CLONE RELATED TO HUMAN CYTOCHROME-P-450 NIFEDIPINE OXIDASE [J].

BEAUNE, PH ;

UMBENHAUER, DR ;

BORK, RW ;

LLOYD, RS ;

GUENGERICH, FP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8064-8068

[6]

BENET LZ, 1996, GOODMAN GILMANS PHAR, P14

[7] Assessment of the potential for a pharmacokinetic interaction between fluoxetine and terfenadine [J].

Bergstrom, RF ;

Goldberg, MJ ;

Cerimele, BJ ;

Hatcher, BL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (06) :643-651

[8] Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].

Bertilsson, G ;

Heidrich, J ;

Svensson, K ;

Åsman, M ;

Jendeberg, L ;

Sydow-Bäckman, M ;

Ohlsson, R ;

Postlind, H ;

Blomquist, P ;

Berkenstam, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213

[9] SXR, a novel steroid and xenobiotic-sensing nuclear receptor [J].

Blumberg, B ;

Sabbagh, W ;

Juguilon, H ;

Bolado, J ;

van Meter, CM ;

Ono, ES ;

Evans, RM .

GENES & DEVELOPMENT, 1998, 12 (20) :3195-3205

[10]

BROWN MB, 1997, J CLIN INVEST, V99, P2545

← 1 2 3 4 5 6 7 8 9 10 →